Madrid – Alantra Private Equity has announced today the signing of an agreement for the acquisition and integration of the three Spain-headquartered genetic diagnostic companies Imegen, Genycell Biotech and Health in Code. The agreement contemplates that the management teams of the three companies will maintain significant stakes in the new group and will continue leading … Continue reading Alantra Private Equity creates the Spanish leader in genetic diagnosis